Hub Gene and Its Key Effects on Diffuse Large B-Cell Lymphoma by Weighted Gene Coexpression Network Analysis

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2021 Dec 7

PMID 34873574

Citations 3

Authors

Chao Ma

Haoyu Li

Affiliations

Soon will be listed here.

Abstract

Diffuse large B-cell lymphoma (DLBC) is a kind of tumor with rapid progress and poor prognosis. Therefore, it is necessary to explore new biomarkers or therapeutic targets to assist in diagnosis or treatment. This study is aimed at screening hub genes by weighted gene coexpression network analysis (WGCNA) and exploring the significance of overall survival (OS) in DLBC patients. Statistical data using WGCNA to analyze mRNA expression in DLBC patients came from The Cancer Genome Atlas (TCGA) dataset. After analyzing with clinical information, the biological functions of hub genes were detected. Survival analysis, Cox regression detection, and correlation analysis of the hub genes were carried out. The potential function of the hub gene related to prognosis was predicted by gene set enrichment analysis (GSEA). The results showed that , , , and expression in normal tissues was significantly higher than that in cancer tissues ( < 0.01). Survival analysis showed that patients with high and were associated with better OS ( < 0.01). and genes were mainly enriched in the regulation of ROS and oxidative stress. The two hub genes related to the prognosis of DLBC were identified and verified based on WGCNA. Survival analysis showed that the overexpression of and in DLBC might be beneficial to the prognosis. These findings identified vital pathways and genes that may become new therapeutic targets and contribute to prognostic indicators.

Citing Articles

Identification of immune-related genes and development of a prognostic model in mantle cell lymphoma.

Zhang W, Shi J, Wang H, Zhang T, Zhou X, Zhang H Ann Transl Med. 2023; 10(24):1323.

PMID: 36660618 PMC: 9843426. DOI: 10.21037/atm-22-5815.

Integrative Bioinformatics Analysis Reveals CHEK1 and UBE2C as Luminal A Breast Cancer Subtype Biomarkers.

Yu D, Liu S, Chen Y, Yang L Front Genet. 2022; 13:944259.

PMID: 35903365 PMC: 9322798. DOI: 10.3389/fgene.2022.944259.

A Potential Diagnostic and Prognostic Biomarker TMEM176B and Its Relationship With Immune Infiltration in Skin Cutaneous Melanoma.

Jiang L, Yang Y, Liu F, Ma M, Gao J, Sun L Front Cell Dev Biol. 2022; 10:859958.

PMID: 35399535 PMC: 8986129. DOI: 10.3389/fcell.2022.859958.

References

ROCHEFORT H . Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer. 1992; 28A(11):1780-3. DOI: 10.1016/0959-8049(92)90003-k. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Adler A, Chang H . From description to causality: mechanisms of gene expression signatures in cancer. Cell Cycle. 2006; 5(11):1148-51. DOI: 10.4161/cc.5.11.2798. View

Phipps C, Lee Y, Ying H, Nagarajan C, Grigoropoulos N, Chen Y . The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma. Leuk Lymphoma. 2018; 59(10):2336-2341. DOI: 10.1080/10428194.2017.1422863. View

Liu R, Cheng Y, Yu J, Lv Q, Zhou H . Identification and validation of gene module associated with lung cancer through coexpression network analysis. Gene. 2015; 563(1):56-62. DOI: 10.1016/j.gene.2015.03.008. View

Losch A, Kohlberger P, Gitsch G, Kaider A, Breitenecker G, Kainz C . Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Br J Cancer. 1996; 73(12):1525-8. PMC: 2074555. DOI: 10.1038/bjc.1996.287. View

Jacq C, Miller J, Brownlee G . A pseudogene structure in 5S DNA of Xenopus laevis. Cell. 1977; 12(1):109-20. DOI: 10.1016/0092-8674(77)90189-1. View

Huang D, Sherman B, Lempicki R . Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2008; 37(1):1-13. PMC: 2615629. DOI: 10.1093/nar/gkn923. View

Rossi A, Orecchioni S, Falvo P, Tabanelli V, Baiardi E, Agostinelli C . Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma. Leukemia. 2021; 36(1):197-209. PMC: 8727301. DOI: 10.1038/s41375-021-01347-6. View

10.

Weinstein J, Collisson E, Mills G, Mills Shaw K, Ozenberger B, Ellrott K . The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013; 45(10):1113-20. PMC: 3919969. DOI: 10.1038/ng.2764. View

11.

Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559. PMC: 2631488. DOI: 10.1186/1471-2105-9-559. View

12.

Vetvicka V, Vetvickova J, Benes P . Role of enzymatically inactive procathepsin D in lung cancer. Anticancer Res. 2004; 24(5A):2739-43. View

13.

Wight J, Yue M, Keane C, Johnston A, Linton K, Chin C . Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance. Br J Haematol. 2019; 187(2):174-184. DOI: 10.1111/bjh.16064. View

14.

Tao Q, Chen Y, Liu Z, Sun Y, Yang P, Lu S . Associations between apolipoprotein E genotypes and serum levels of glucose, cholesterol, and triglycerides in a cognitively normal aging Han Chinese population. Clin Interv Aging. 2014; 9:1063-7. PMC: 4096455. DOI: 10.2147/CIA.S62554. View

15.

Udyavar A, Hoeksema M, Clark J, Zou Y, Tang Z, Li Z . Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer. BMC Syst Biol. 2014; 7 Suppl 5:S1. PMC: 4029366. DOI: 10.1186/1752-0509-7-S5-S1. View

16.

Niemira M, Collin F, Szalkowska A, Bielska A, Chwialkowska K, Reszec J . Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA). Cancers (Basel). 2019; 12(1). PMC: 7017323. DOI: 10.3390/cancers12010037. View

17.

Yang Y, Han L, Yuan Y, Li J, Hei N, Liang H . Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types. Nat Commun. 2014; 5:3231. PMC: 3951205. DOI: 10.1038/ncomms4231. View

18.

Liu H, Shui I, Platz E, Mucci L, Giovannucci E . No Association of ApoE Genotype with Risk of Prostate Cancer: A Nested Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2015; 24(10):1632-4. PMC: 4743244. DOI: 10.1158/1055-9965.EPI-15-0367. View

19.

Shi Z, Derow C, Zhang B . Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression. BMC Syst Biol. 2010; 4:74. PMC: 2902438. DOI: 10.1186/1752-0509-4-74. View

20.

Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J . Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006; 98(4):262-72. DOI: 10.1093/jnci/djj052. View